Impact of Major Health Events on Pharmaceutical Stocks: A Comprehensive Analysis Using Macroeconomic and Market Indicators

Morteza Maleki,SeyedAli Ghahari
2024-08-04
Abstract:This study investigates the impact of significant health events on pharmaceutical stock performance, employing a comprehensive analysis incorporating macroeconomic and market indicators. Using Ordinary Least Squares (OLS) regression, we evaluate the effects of thirteen major health events since 2000, including the Anthrax attacks, SARS outbreak, H1N1 pandemic, and COVID-19 pandemic, on the pharmaceutical sector. The analysis covers different phases of each event beginning, peak, and ending to capture their temporal influence on stock prices. Our findings reveal distinct patterns in stock performance, driven by market reactions to the initial news, peak impact, and eventual resolution of these crises. We also examine scenarios with and without key macroeconomic (MA) and market (MI) indicators to isolate their contributions. This detailed examination provides valuable insights for investors, policymakers, and stakeholders in understanding the interplay between major health events and health market dynamics, guiding better decision-making during future health related disruptions.
Computational Engineering, Finance, and Science
What problem does this paper attempt to address?
### What problem does this paper attempt to solve? This paper aims to explore the impact of major health events on the performance of pharmaceutical stocks and to evaluate the specific effects of these events on stock prices at different stages (beginning, peak, end) through a comprehensive analysis of macroeconomic indicators and market indicators. Specifically: 1. **Impact of Major Health Events**: - The paper analyzes 13 major health events since 2000, including the anthrax attacks, SARS epidemic, H1N1 influenza pandemic, and COVID-19 pandemic, to investigate how these events affect the stock prices of the pharmaceutical industry. 2. **Role of Macroeconomic and Market Indicators**: - The study includes multiple macroeconomic indicators (such as GDP, inflation rate, unemployment rate) and market indicators (such as the S&P 500 index, Nasdaq index) to understand their roles during health crises. 3. **Analysis of Different Stages**: - The paper pays special attention to the different stages of each health event (beginning, peak, end) to capture the market's time-dynamic response to these events. 4. **Providing Decision Support**: - Through detailed analysis, the research provides valuable insights for investors, policymakers, and industry stakeholders, helping them make better decisions during future health-related crises. Through these comprehensive analyses, the paper aims to reveal specific patterns and trends in the impact of health events on pharmaceutical industry stock prices, thereby providing more scientific investment and policy guidance for relevant parties.